Focus on Healthcare & Biotechnology Investor Relations
Stern IR is the premier investor relations firm focusing on the entrepreneurial healthcare and biotechnology industries.
We have comprehensive, up-to-the-minute knowledge of the technical, regulatory and financial aspects of this very dynamic industry. We closely monitor industry trends to provide a comprehensive, data-driven approach to investor relations counsel.
We keep up to date on the frequent changes in the financial markets and the healthcare and biotechnology industries, and harness that knowledge to create personalized communications strategies. In addition, our clients’ needs change also: Stern IR recognizes the importance of routinely re-evaluating each client's IR program to address evolving corporate needs and the macro environment, in order to ensure maximum impact from the IR program.
We have longstanding and personal relationships with our clients and tailor each IR program to each client's specific needs and goals. We are committed to superior client service and are dedicated to providing senior level attention, strategic counsel and critical, disciplined tactical support.
Access: Key Relationships with the Healthcare and
Biotechnology Investment Community
As specialists in healthcare and biotechnology, we have cultivated valuable relationships within the investment community and know how to direct companies on who to meet, where to be, and when. We facilitate introductions and communications with crucial contacts on Wall Street and help our clients develop and improve existing relationships.
In the biotechnology sector, investor conferences and industry events are an important part of a successful IR program. We leverage our relationships in the industry to target the highest quality events for each client and to help obtain the most value from each event. Through a combination of meetings and roadshows, we familiarize the financial community with our clients and their unique prospects.
Focus on Best Investor Relations Practices
While each client has its own set of specific goals and tactics, we believe that high-quality companies should operate their investor relations programs according to current best industry practice. By coupling our deep experience with a reliance on data, we are able to offer our clients comprehensive guidance.
We work with our clients to communicate news and information to research analysts and investors regularly and consistently, with special attention to timing, position, accuracy, and fair disclosure practices. In addition, we provide appropriate guidance to clients to ensure they maintain the respect and trust that is vital to a company's reputation on Wall Street.